We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Transplant Patient Registry of Liver, Kidney and/or Pancreas

This study is currently recruiting participants.
Verified July 2017 by Virginia Commonwealth University
Sponsor:
ClinicalTrials.gov Identifier:
NCT00238693
First Posted: October 13, 2005
Last Update Posted: July 28, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Virginia Commonwealth University
  Purpose
This is a registry of data collected from patient records, both of those who have a condition which may require transplantation and those who have undergone transplantation of the liver, kidney and/or pancreas.

Condition
End Stage Renal Disease End Stage Liver Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Transplant Registry: Patients Who May Require Transplantation and Those Who Have Undergone Transplantation of Liver, Kidney and/or Pancreas

Resource links provided by NLM:


Further study details as provided by Virginia Commonwealth University:

Primary Outcome Measures:
  • Data collection and maintenance [ Time Frame: Ongoing ]
    MAINTAIN A CURRENT, ACCURATE DATA BASE OF TRANSPLANT RECIPIENTS WITH REGARDS TO TRANSPLANT DATA AND OUTCOMES.


Estimated Enrollment: 15000
Study Start Date: April 2003
Estimated Study Completion Date: January 2025
Estimated Primary Completion Date: January 2025 (Final data collection date for primary outcome measure)
Detailed Description:
Honest Broker arrangement.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients followed in the transplant clinic at Virginia Commonwealth University Health System
Criteria

Inclusion Criteria:

  • Patients followed in the transplant clinic at Virginia Commonwealth University Health System
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00238693


Contacts
Contact: Adrian H Cotterell, MD, FACS 804-828-8911
Contact: Mary W Baldecchi, RN, BSN, CCRC 804-828-7925 mary.baldecchi@vcuhealth.org

Locations
United States, Virginia
Virginia Commonwealth University Health System Recruiting
Richmond, Virginia, United States, 23298
Contact: Adrian H Cotterell, MD, FACS    804-828-8911      
Sponsors and Collaborators
Virginia Commonwealth University
Investigators
Principal Investigator: Adrian H Cotterell, MD, FACS Virginia Commonwealth University Health System
  More Information

Responsible Party: Virginia Commonwealth University
ClinicalTrials.gov Identifier: NCT00238693     History of Changes
Other Study ID Numbers: HM3127
First Submitted: October 11, 2005
First Posted: October 13, 2005
Last Update Posted: July 28, 2017
Last Verified: July 2017

Keywords provided by Virginia Commonwealth University:
transplant
transplantation of liver, kidney, pancreas

Additional relevant MeSH terms:
Liver Diseases
Kidney Failure, Chronic
End Stage Liver Disease
Digestive System Diseases
Renal Insufficiency, Chronic
Renal Insufficiency
Kidney Diseases
Urologic Diseases
Liver Failure
Hepatic Insufficiency
Pancrelipase
Pancreatin
Gastrointestinal Agents


To Top